The Efficacy of a Nerve Stimulator (Cavermap®) to Enhance Autonomic Nerve Identification and Confirm Nerve Preservation During Total Mesorectal Excision
- 1 December 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 47 (12) , 2032-2038
- https://doi.org/10.1007/s10350-004-0718-5
Abstract
Sexual dysfunction after total mesorectal excision may be caused by injury to the autonomic nerves. During surgery, nerve identification is not always achieved, and, to date, there has been no method to objectively confirm nerve preservation. The aim of this study was to assess the efficacy of a nerve-stimulating device (CaverMap®) to assist in the intraoperative identification of the autonomic nerves during total mesorectal excision, and objectively confirm nerve preservation after proctectomy is completed. Sexually active consecutive male patients undergoing total mesorectal excision were prospectively enrolled in this study. During pelvic dissection, the surgeon attempted to localize the hypogastric and cavernous nerves. Cavermap® was used to confirm these findings and to facilitate the identification in cases of uncertainty. At the completion of proctectomy, the nerves were restimulated to ensure preservation. Factors that could affect the surgeon's ability to localize the nerves and Cavermap® to confirm this were evaluated. Twenty-nine male patients with a median age of 58 years were enrolled in this study. An attempt to visualize the hypogastric nerves during dissection was made in 26 patients; the surgeon was able to identify the nerves in 19 (73 percent) patients. Cavermap® successfully identified the nerves in six of the seven remaining patients, and failed to identify them in only one case. An attempt to localize the cavernous nerves during dissection was made in 13 patients, of which localization was successful in 8 (61.5 percent) patients. Cavermap® improved the identification rate in four of the remaining five patients. After proctectomy, Cavermap® successfully confirmed the preservation of both hypogastric and cavernous nerves in 27 of 29 (93 percent) patients. A history of previous surgery statistically correlated with failure to identify the hypogastric nerves by the surgeon (P= 0.005). There were no adverse events related to use of the device. Cavermap® may be a useful tool to facilitate identification of the pelvic autonomic nerves during total mesorectal excision and to objectively confirm nerve preservation.Keywords
This publication has 10 references indexed in Scilit:
- Influence of Identification and Preservation of Pelvic Autonomic Nerves in Rectal Cancer Surgery on Bladder Dysfunction After Total Mesorectal ExcisionDiseases of the Colon & Rectum, 2003
- Intraoperative Parasympathetic Nerve Stimulation with Tumescence Monitoring During Total Mesorectal Excision for Rectal CancerJournal of the American College of Surgeons, 2002
- Autonomic nerve preserving total mesorectal excisionSurgical Clinics of North America, 2002
- Assessment of Sexual and Voiding Function After Total Mesorectal Excision With Pelvic Autonomic Nerve Preservation in Males With Rectal CancerDiseases of the Colon & Rectum, 2002
- A RANDOMIZED PHASE 3 STUDY OF INTRAOPERATIVE CAVERNOUS NERVE STIMULATION WITH PENILE TUMESCENCE MONITORING TO IMPROVE NERVE SPARING DURING RADICAL PROSTATECTOMYJournal of Urology, 2000
- A positive caver map response poorly predicts recovery of potency after radical prostatectomyUrology, 2000
- Avoiding long-term disturbance to bladder and sexual function in pelvic surgery, particularly with rectal cancerSeminars in Surgical Oncology, 2000
- Ileal J-Pouch-Anal Anastomosis, Sexual Dysfunction, and FertilityScandinavian Journal of Gastroenterology, 1999
- Radical and nerve-preserving surgery for rectal cancer in the Netherlands: a prospective study on morbidity and functional outcomeBritish Journal of Surgery, 1998
- The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?British Journal of Surgery, 1982